The U.S. Hemp Roundtable has been meeting with White House officials to discuss the forthcoming guidance on CBD products from the U.S. Federal Drug Administration (FDA). We hope to ensure that the WH and the #FDA establish regulatory certainty for the sale of #CBD products and to provide a safe harbor for products that are manufactured according to all other FDA requirements. As discussions progress, we will share what information we can about the potential pathway forward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.